Written by Ad OpsOverview: What Is The White (CBD)?
The White (CBD) refers to CBD-forward selections and crosses derived from the legendary resin-bomb known as The White. Where classic The White is prized for its blizzard of trichomes and balanced to potent THC expressions, the CBD variant emphasizes cannabidiol for a clearer, less intoxicating experience. Growers and breeders achieve this by selecting rare CBD-leaning phenotypes or, more commonly, by crossing The White with established high-CBD lines.
In practical terms, that means The White (CBD) can present a range of THC:CBD ratios, from nearly hemp-like profiles to balanced 1:1 chemotypes. Consumers often seek it for daytime relief, functional calm, or to access The White’s hallmark resin quality without heavy psychoactivity. The result is a cultivar family that preserves the “snowed-in” frosty look while pivoting the cannabinoid payload toward CBD.
Because “The White (CBD)” is a breeding outcome rather than a single, uniform clone-only, its lab numbers can vary by breeder, region, and phenotype. Nonetheless, the shared traits—dense frost, subtle nose, and clean, centered effects—make this CBD-forward expression distinctive. For many, it’s an elegant bridge between heritage craft cannabis and modern, wellness-leaning chemotypes.
History and Origin of The White and the CBD Variant
The White emerged from Florida’s underground scene in the late 1990s and 2000s, popularized by a grower known as Krome. It quickly earned a reputation for extreme trichome density that turned flowers visibly white at maturity. Unlike loud, diesel- or kush-forward classics, The White was notorious for a muted aroma but staggering resin output, making it a breeder’s staple.
CBD-oriented versions began appearing as medical markets matured and demand grew for low- to mid-THC, high-CBD flower. Breeders selectively crossed The White into high-CBD parents (e.g., Cannatonic, ACDC, or CBD-forward White Widow lines) to produce offspring with heavier CBD fractions. This evolution tracked the broader industry trend toward targeted cannabinoid outcomes beyond THC alone.
A related parallel is the rise of purpose-bred minor cannabinoid cultivars, such as CBG-dominant hemp. Leafly has highlighted farms like Oregon CBD, which won awards for a cultivar named White CBG containing around 10% CBG and less than 0.3% THC, demonstrating how breeders use resinous “white” lines to host novel cannabinoid profiles. Although White CBG is not the same as The White (CBD), it illustrates how trichome-rich genetics can serve as a chassis for non-THC outcomes.
As CBD became mainstream, seedbanks began listing CBD-dominant versions of legacy winners. For instance, CBD White Widow Autoflower has been offered with minimal THC (0–5%) and high CBD (5–10%), showing how the iconic “White” lineage has been repurposed for therapeutic users. The White (CBD) sits squarely in this continuum, blending high-resin aesthetics with gentler, CBD-led effects.
Genetic Lineage and Breeding Pathways
The original The White’s genetics have long been described as ambiguous, often rumored to connect to Triangle Kush or Florida lines. What’s clear is that its defining trait is not a singular aroma or stretch pattern, but its blanket of resin glands and excellent calyx development. Breeding projects have repeatedly leveraged these traits to boost trichome coverage in progeny.
To create The White (CBD), breeders typically cross The White with CBD-heavy cultivars such as Cannatonic (frequently 1:1 THC:CBD) or ACDC (often 20:1 CBD:THC), or with CBD-forward versions of White Widow. Seed marketplace data lists CBD White Widow Autoflower with 5–10% CBD and up to 0–5% THC, a ratio that many The White (CBD) projects target or approximate. The goal is to stack CBD alleles while maintaining The White’s resin-blizzard phenotype.
Because chemotype inheritance is quantitative and polygenic, outcomes vary across filial generations and phenohunts. Growers often sort through dozens of seedlings to isolate CBD-dominant or 1:1 phenotypes, then stabilize via backcrossing or selfing. The final “The White (CBD)” product in a given market is thus a curated expression, not a monolith, explaining the variability consumers may see.
A practical way to picture it is as a triangle: one vertex anchored by The White’s resin and structure, a second by a high-CBD donor, and a third by environmental expression. Breeders tune each vertex through selection and cultivation, slowly converging on repeatable CBD-rich chemotypes. Over time, elite cuts become regional standards passed from cultivator to cultivator.
Appearance and Morphology
The White (CBD) lives up to its name with thick blankets of glandular trichomes that lend mature buds a frosted, even sugar-dusted look. Cola structure tends to be dense and golf-ball to spear-shaped, with a high calyx-to-leaf ratio that supports efficient trimming. The pistils range from pale tangerine to rusty orange, standing out against the pale lime and forest-green backdrop.
Under magnification, capitate-stalked trichomes are abundant, with bulbous heads that cloud from clear to milky as harvest approaches. The resin heads are typically uniform and plentiful, a trait inherited from The White and zealously preserved in CBD selections. Sugar leaves are short and broad, often so coated that even small fan leaves may glisten at peak ripeness.
Internodal spacing is compact to moderate, contributing to a manageable canopy in small tents and commercial tables alike. Plants display hybrid vigor with sturdy lateral branching, which responds well to topping and light training. In flower, bract stacking can be pronounced, producing tight, chunky flowers that cure into firm, tacky nuggets.
Expect an overall tidy plant architecture ideal for sea-of-green (SOG) or low-stress training (LST) setups. With dialed-in environmental controls, resin coverage can be exceptional, making it a favorite for ice water hash makers and rosin producers. Those visual hallmarks are also an easy quality tell for consumers inspecting jarred buds.
Aroma and Bouquet
Classic The White is known for a restrained nose, and The White (CBD) typically follows suit with a subtle, refined bouquet. The dominant top notes often include fresh pine and faint lemon rind, layered over soft earth, oat-like grain, and light pepper. When broken up, buds may release a whisper of herbal sweetness and a cool, menthol-adjacent freshness.
In environments that push terpene expression, a gentle fusion of caryophyllene spice and myrcene musk can emerge. Some phenotypes lean into a subdued floral character, like crushed chamomile and sweetgrass. Compared to diesel or chem cultivars, the aroma footprint is discreet, which many home growers appreciate.
Post-cure, the bouquet concentrates into cleaner, brighter tones. Jar aroma often reads as pine-lime with a dry biscuit undertone and faint hops. The understated aromatic profile, while not as ostentatious as dessert cultivars, aligns with the cultivar’s functional, CBD-forward intent.
Flavor and Mouthfeel
On the palate, The White (CBD) is crisp and honest, delivering pine needles, light citrus peel, and white pepper across the tongue. The initial draw is typically smooth, with a cooling sensation that echoes eucalyptus or mint without veering into candy-terp territory. Exhale brings out dry earth, toasted grain, and a lingering, peppery finish.
Vaporized at lower temperatures (170–185°C), the flavor skews toward lime zest, sweet herb, and gentle woodiness. At higher temperatures or in joints, pepper-caryophyllene and hoppy humulene step forward, with a subtle bitterness that pairs well with unsweetened tea or sparkling water. The mouthfeel remains dry and clean, making it easy to session.
Edible infusions retain a quiet herbal-pine character that doesn’t overwhelm culinary applications. Butter or coconut oil extractions can carry a faint biscuit note into baked goods. Tinctures tend to present as peppered citrus, especially when limonene and pinene are prominent in the terpene assay.
Cannabinoid Profile, Ratios, and Lab Stats
Because The White (CBD) is a breeding class rather than a single cut, cannabinoid ratios span a realistic range depending on selection and test lab. In legal markets, CBD-dominant flower commonly tests between 8–15% CBD by dry weight with THC anywhere from <0.3% (hemp compliance) to ~5% in more balanced phenotypes. A 1:1 chemotype may read in the 6–10% range for both cannabinoids, while 20:1 CBD:THC phenotypes cluster around 10–15% CBD and 0.3–1% THC.
Seed marketplace benchmarks help contextualize expectations. For example, CBD White Widow Autoflower is listed with Minimum (0–5%) THC and High (5–10%) CBD, a ratio archetype many The White (CBD) projects mirror to deliver low intoxication with noticeable somatic relief. Dutch Passion notes that many medical users favor concentrated CBD oils from CBD-rich strains, underscoring demand for chemotypes capable of yielding potent extracts without high THC.
Total cannabinoid content (sum of major and minors) typically lands in the 12–20% range for CBD-dominant flower, depending on cultivation intensity and harvest timing. Minor cannabinoids like CBG often appear at 0.2–1.0%, with CBC occasionally detectable in trace to low amounts. While not a CBG-dominant cultivar, some phenotypes may express elevated CBG precursors earlier in flowering, a trait seen industry-wide during cannabinoid biosynthesis.
Two practical notes improve outcomes for consumers and growers. First, cannabinoid percentages can swing by several points with environmental shifts—light intensity, nutrition, and harvest window all matter. Second, decarboxylation efficiency and post-harvest handling can meaningfully impact realized CBD content in edibles and tinctures, often by ±5–10% relative to raw assay values.
Terpene Profile and How It Shapes Effects
Terpenes are aromatic compounds that contribute both to flavor and to the qualitative feel of cannabis, and research has explored their interactions with neuronal and peripheral receptors. Leafly’s educational resources describe how terpenes, like cannabinoids, engage with receptor systems and can modulate perceived effects—myrcene often relaxing, limonene uplifting, and beta-caryophyllene acting as a CB2 receptor agonist. The White (CBD) tends to feature a restrained but purposeful blend that shapes its clear-headed calm.
Lab reports on CBD-forward expressions of White-line genetics commonly list myrcene, beta-caryophyllene, alpha- and beta-pinene, humulene, and limonene among top contributors. Myrcene is frequently associated with body ease; caryophyllene with anti-inflammatory and stress-buffering potential; pinene with alertness and bronchodilation; humulene with a dry, hoppy character and potential appetite-suppressing properties; and limonene with brighter mood tone. Total terpene content for dialed-in indoor runs often lands between 1.0–2.5% by weight.
For context, Leafly notes that terpenes determine much of cannabis’s scent and contribute to flavor, which helps explain The White (CBD)’s pine-citrus-pepper signature. Similarly, White Widow-related literature often highlights myrcene and caryophyllene dominance, a pattern that can bleed into White-family CBD crosses through shared heritage. This overlap aligns with consumer reports describing a calm but attentive headspace with soothing body notes.
In practice, terpenes do not operate in isolation. The entourage effect hypothesis posits that cannabinoid-terpene synergy can change the subjective profile of a given chemotype. Users frequently report that The White (CBD)’s pepper-pine-lime trio delivers a stable, grounded effect well-suited to daytime focus without heaviness.
Experiential Effects: Onset, Duration, and Functional Feel
With CBD in the driver’s seat, intoxication is typically minimal to mild unless the phenotype is 1:1 or higher in THC. Many consumers describe a clear, centered onset within 5–10 minutes of inhalation, transitioning into a calm, body-light sensation that lacks the raciness some experience with high-THC sativas. The mood lift is steady and composed rather than euphoric or buzzy.
Vaped or smoked, peak effects usually arrive by 20–30 minutes and taper over 90–150 minutes depending on dose and tolerance. Edible infusions extend the arc, with onset around 45–90 minutes and duration of 3–6 hours. Because CBD can attenuate THC’s psychoactivity, balanced phenotypes often feel gentler and more linear than THC-dominant counterparts.
Functionally, users often reach for The White (CBD) for daytime stress management, task-friendly relaxation, and post-exercise recovery. The pinene-limonene lift, paired with caryophyllene’s grounding body tone, supports concentration without sedation in many reports. Appetite stimulation is modest, and couchlock is uncommon unless doses are high or myrcene loads are unusually elevated.
Of note, White-family genetics have historically been linked with creative stimulation and conversational energy in variants like White Papaya and White Buffalo, as summarized in strain writeups. While The White (CBD) does not typically match those THC-forward surges, a similar “capability feel” often shows through—steady motivation, reduced distraction, and comfortable sociability. As always, individual responses vary with set, setting, and dose.
Potential Medical Uses: What the Evidence Suggests
CBD has been studied for anxiety, seizure disorders, inflammation, and pain modulation, though results vary by condition, dose, and formulation. In randomized trials for certain pediatric epilepsies, pharmaceutical-grade CBD has produced clinically meaningful seizure reductions, with median decreases often cited around 30–40% versus baseline. While whole-flower chemovars like The White (CBD) are not identical to purified products, their CBD load and caryophyllene-rich terpene profiles are consistent with many users’ real-world goals.
For anxiety and stress, observational data and small trials suggest CBD may reduce self-reported anxiety in acute settings, with doses commonly ranging from 25–300 mg in studies using oral formats. Terpenes such as limonene and linalool (if present) are frequently reported to contribute calming or mood-brightening effects, while pinene may preserve mental clarity. The White (CBD)’s balanced terpene palette supports these aims without overt sedation for most users.
Pain and inflammation are complex targets. Beta-caryophyllene is unique among common terpenes as a selective CB2 agonist, a receptor associated with inflammatory pathways; preclinical research indicates potential analgesic and anti-inflammatory activity. Human evidence for CBD in chronic pain is mixed but suggestive, with meta-analyses indicating small-to-moderate effect sizes in some neuropathic and inflammatory pain contexts.
Sleep outcomes tend to be dose dependent: lower to moderate CBD doses may be alerting or neutral, while higher doses can be sedating in some individuals. Myrcene-rich expressions can nudge toward relaxation, potentially aiding sleep onset without heavy next-day fog. Consumers often deploy The White (CBD) as an evening wind-down tool when anxiety and muscular tension are the bottlenecks rather than primary insomnia.
From a harm-reduction perspective, CBD-dominant flower offers an on-ramp for patients seeking cannabinoid benefits without strong intoxication. Dutch Passion underscores that concentrated CBD oils derived from CBD-rich cultivars are particularly beneficial for many medical users, a pattern consistent with clinical practice where precise dosing is preferred. Regardless, individuals should consult healthcare professionals, especially when combining CBD with other medications, due to known CYP450 interactions.
Cultivation Guide: Environment, Feeding, and Training
The White (CBD) is a rewarding indoor or greenhouse cultivar that performs well under moderate vigor with strong resin output. Vegeta
